Table 5 Clinicopathological features of patients with concomitant EGFR and ALK alterations.
Features | P1 | P2 | P3 | P4 | P5 |
|---|---|---|---|---|---|
Age | 70 | 64 | 43 | 51 | 64 |
Sex | F | M | M | M | F |
Smoking | no | yes | yes | no | no |
Stage | IA | IIIA | IA | IIIA | IA |
EGFR mutation | E19 del (2235–2249) | E19 del (2240–2257) | E19 del (2235–2257) | E21L858R | E21L858R |
ALK Ventana IHC | + | + | + | + | + |
KRAS | WT | WT | WT | WT | WT |
BRAF | WT | WT | WT | WT | WT |
HER-2 | WT | WT | WT | WT | WT |
